Abstract:Background: Esophageal squamous cell carcinoma (ESCC), a prevalent malignancy within the upper gastrointestinal system, is characterized by its unfavorable prognosis and the absence of specific indicators for outcome prediction and high-risk case identification. In our research, we examined the expression levels of cancer stem cells (CSCs), markers CD44/SOX2 in ESCC, scrutinized their association with clinicopathological parameters, and developed a predictive nomogram model. This model, which incorporates CD44/SOX2, aims to forecast the overall survival (OS) of patients afflicted with ESCC. Methods: Immunohistochemistry was utilized to detect the expression levels of CD44 and SOX2 in both cancerous and paracancerous tissues of 68 patients with ESCC. The correlation between CD44/SOX2 expression and clinicopathological parameters was subsequently analyzed. Factors impacting the prognosis of ESCC patients were assessed through univariate and multivariate Cox regression analyses. Leveraging the results of these multivariate regression analyses, a nomogram prognostic model was established to provide individualized predictions of ESCC patient survival outcomes. The predictive accuracy of the nomogram prognostic model was evaluated using the consistency index (C-index) and calibration curves. Results: The expression levels of CD44 were markedly elevated in the tumor tissues of ESCC patients. Similarly, SOX2 was significantly overexpressed in the tumor tissues of ESCC patients. The positive expression of SOX2 in ESCC demonstrated a strong correlation with both the pathological T-stage and the presence of carcinoembryonic antigen. CD44 and SOX2 co-positive expression was significantly associated with the pathological T-stage and tumor node metastasis (TNM) stage. Furthermore, ESCC patients exhibiting CD44-positive expression in their tumor tissue generally had a more adverse prognosis. The co-expression of CD44 and SOX2 resulted in a grimmer prognosis compared to patients with other combinations. Multivariate Cox regression analysis identified the co-expression of CD44 and SOX2, the pathological T-stage, and lymph node metastasis as independent prognostic indicators for ESCC patients. The three identified variables were subsequently incorporated into a nomogram for predicting OS. The C-index of the measurement model and the area under the curve of the subjects' work characteristics showed good individual prediction. This prognostic model stratified patients into low- and high-risk categories. Analysis revealed that the 5-year OS rate was significantly higher in the low-risk group compared to the high-risk group. Conclusions: Elevated CD44 levels, indicative of CSC presence, are intimately linked with the oncogenesis of ESCC and are strongly predictive of unfavorable patient outcomes. Concurrently, the SOX2 gene exhibits a heightened expression in ESCC, markedly accelerating tumor progression and fostering more extensive disease infiltration. The co-expression of CD44 and SOX2 correlates significantly with ESCC patient prognosis, serving as a reliable, independent prognostic marker. Our constructed nomogram, incorporating CD44/SOX2 expression, enhances the prediction of OS and facilitates risk stratification in ESCC patients.

Epigenetic Regulation Of Cd271, A Potential Cancer Stem Cell Marker Associated With Chemoresistance And Metastatic Capacity

Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma

CD276 Expression Enables Squamous Cell Carcinoma Stem Cells to Evade Immune Surveillance.

Identification of Cancer Stem Cell Molecular Markers and Effects of Hsa-Mir-21-3p on Stemness in Esophageal Squamous Cell Carcinoma.

CD276 regulates the immune escape of esophageal squamous cell carcinoma through CXCL1–CXCR2 induced NETs

Potential markers of cancer stem-like cells in esophageal squamous cell carcinoma: A review of the current knowledge

Cancer Stem-Like Cells Enriched with CD29 and CD44 Markers Exhibit Molecular Characteristics with Epithelial–mesenchymal Transition in Squamous Cell Carcinoma

Clinical and biological significance of stem-like CD133+CXCR4+ cells in esophageal squamous cell carcinoma

Correlation Of Cd133, E-Cadherin, And Beta-Catenin With Metastasis And Prognosis In Esophageal Squamous Cell Carcinoma

The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.

Epigenetic Induction of Tumor Stemness Via the Lipopolysaccharide-Tet3-hoxb2 Signaling Axis in Esophageal Squamous Cell Carcinoma

The Expression Status and Prognostic Value of Cancer Stem Cell Biomarker Cd133 in Cutaneous Squamous Cell Carcinoma

CD276 suppresses CAR-T cell function by promoting tumor cell glycolysis in esophageal squamous cell carcinoma

Identification and Characterization of Metastasis‐Initiating Cells in ESCC in a Multi‐Timepoint Pulmonary Metastasis Mouse Model

Identification of New Cancer Stem Cell Markers and Signaling Pathways in HER‑2‑positive Breast Cancer by Transcriptome Sequencing.

Progress in research of markers for cancer stem cells in esophageal squamous cell carcinoma

Ecto-5'-nucleotidase (CD73) is a Biomarker for Clear Cell Renal Carcinoma Stem-Like Cells

Dysregulation of CXCL14 promotes malignant phenotypes of esophageal squamous carcinoma cells via regulating SRC and EGFR signaling

Cancer Stem Cell markers: Symphonic masters of chemoresistance and immune evasion

Clinicopathological significance of cancer stem cell marker CD44/SOX2 in esophageal squamous cell carcinoma (ESCC) patients and construction of a nomogram to predict overall survival

NEDD9 Promotes Cancer Stemness by Recruiting Myeloidderived Suppressor Cells Via CXCL8 in Esophageal Squamous Cell Carcinoma